4.5 Article

The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration

期刊

MOLECULAR BIOLOGY REPORTS
卷 48, 期 4, 页码 3463-3474

出版社

SPRINGER
DOI: 10.1007/s11033-021-06364-3

关键词

Cell migration; Cellular mechanisms; Hepatic disease; Lipid metabolism; Non-coding RNAs; Systems biology

资金

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-2013/21186-5, 2018/05286-3]
  2. CAPES

向作者/读者索取更多资源

Hepatocellular carcinoma is a common cancer with high mortality rate, and controlling fatty acid metabolism may limit its proliferation. Inhibition of miR-1914-5p has been found to change cellular metabolism and behavior, increasing energy expenditure and decreasing cell doubling time and migration rate.
Hepatocellular carcinoma is one of the most common types of cancer in the world with high mortality rate and new therapies that control of fatty acid metabolism may limit the proliferation of cancer cells. In the last two decades, the non-coding RNAs have been considered as promising molecular tools to treat diseases, because they are able to modulate gene expression and the metabolic routes; however, deep investigation of their mechanistic behavior in pathologies must be performed. Thus, our aim was to evaluate the modulatory effect of the miR-1914-5p in controlling lipid metabolism in HepG2, a widely used human hepatocarcinoma cell line. The molecular and cellular analyses demonstrated that the functional inhibition of the investigated microRNA completely changed the cellular metabolism and behavior, compared to control groups. The in vitro inhibition of the miR-1914-5p increased the energy expenditure pointed in different analyses, decreasing cell doubling time and migration rate verified in wound healing and in the classical transwell chambers invasion assays, which makes the miR-1914-5p a candidate for further translational and preclinical studies to validate its function in controlling metastasis in liver cancer or even treat those diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据